Radiopharmaceutical developer North American Scientific reported first-quarter net sales of $3.4 million, down 35% compared with the $5.1 million in sales posted last year. For the period (end-January 31), the Chatsworth, CA-based vendor had a net loss of $3.9 million, compared with a net loss of $1 million in the first quarter a year ago.
The company attributed the sales decrease primarily to the transition from a third-party distribution relationship to direct sales of its brachytherapy seed products. In other developments, the firm said it plans to delay its acquisition of Nomos until the second calendar quarter, due to additional data required by the Securities and Exchange Commission.
By AuntMinnie.com staff writersFebruary 26, 2004
Related Reading
NAS loss widens on one-time charges, May 22, 2002
Philips, Theseus team up, February 21, 2002
NAS moves into the black, February 20, 2002
NAS revenues grow while income dips, December 11, 2001
NAS unit begins clinical Apomate trials, November 30, 2001
Copyright © 2004 AuntMinnie.com
